1. Yang, Su, Wang, Yue-Peng, Li, Xi-Yong, Han, Peng-Yong, Han, Peng-Fei. 2023. The association between ADAM12 gene polymorphisms and osteoarthritis: an updated meta-analysis. In Journal of orthopaedic surgery and research, 18, 149. doi:10.1186/s13018-023-03626-7. https://pubmed.ncbi.nlm.nih.gov/36855121/
2. Wang, Ru, Godet, Ines, Yang, Yongkang, Gilkes, Daniele M, Semenza, Gregg L. . Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis. In Proceedings of the National Academy of Sciences of the United States of America, 118, . doi:10.1073/pnas.2020490118. https://pubmed.ncbi.nlm.nih.gov/33952697/
3. Ren, Kewei, Ruan, Yuan, Tang, Jilei, Gu, Yanqing, Mi, Yuanyuan. 2017. Association of ADAM12 gene polymorphisms with knee osteoarthritis susceptibility. In Oncotarget, 8, 77710-77721. doi:10.18632/oncotarget.20772. https://pubmed.ncbi.nlm.nih.gov/29100419/
4. Du, Shuangqiu, Sun, Linlin, Wang, Yun, Pei, Wenjun, Zhang, Yao. 2022. ADAM12 is an independent predictor of poor prognosis in liver cancer. In Scientific reports, 12, 6634. doi:10.1038/s41598-022-10608-y. https://pubmed.ncbi.nlm.nih.gov/35459884/
5. Mohamad, Amira, Hassan, Rosline, Husin, Azlan, Johan, Muhammad Farid, Sulong, Sarina. 2021. Aberrant Methylation of Tumour Suppressor Gene ADAM12 in Chronic Lympocytic Leukemia Patients: Application of Methylation Specific-PCR Technique. In Asian Pacific journal of cancer prevention : APJCP, 22, 85-91. doi:10.31557/APJCP.2021.22.1.85. https://pubmed.ncbi.nlm.nih.gov/33507683/
6. Duhachek-Muggy, Sara, Zolkiewska, Anna. 2015. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer. In BMC cancer, 15, 93. doi:10.1186/s12885-015-1108-1. https://pubmed.ncbi.nlm.nih.gov/25886595/
7. Sobecki, Michal, Chen, Jing, Krzywinska, Ewelina, Jamora, Colin, Stockmann, Christian. 2022. Vaccination-based immunotherapy to target profibrotic cells in liver and lung. In Cell stem cell, 29, 1459-1474.e9. doi:10.1016/j.stem.2022.08.012. https://pubmed.ncbi.nlm.nih.gov/36113462/
8. Jacobsen, J, Wewer, U M. . Targeting ADAM12 in human disease: head, body or tail? In Current pharmaceutical design, 15, 2300-10. doi:. https://pubmed.ncbi.nlm.nih.gov/19601832/